Search results
Novavax's license deal with Sanofi at lofty valuation sends shares soaring
Reuters· 2 hours ago, opens new tab for COVID-19 vaccines in exchange for a stake that valued the U.S. biotech firm at...
Novavax shares jump 40% on $1.2 billion licensing deal with Sanofi despite Q1 losses | Invezz
Invezz· 4 hours agoNovavax (NASDAQ:NVAX) shares rocketed 40% in premarket trading Friday, driven not only by the...
Novavax stock soars 40% on Sanofi partnership By Investing.com
Investing.com· 5 hours agoNovavax (NASDAQ:NVAX) shares rocketed 40% in premarket trading Friday, driven by the company’s...
Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal
Bloomberg· 6 hours agoHave a confidential tip for our reporters? Novavax Inc. shares surged after the company signed a...
Novavax Stock Surges 120% on $1.4 Billion Deal With Sanofi
Barrons.com· 3 hours agoThe two companies will work on a shot that combines Covid-19 and flu vaccines.Read the full article
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 7 hours agoNovavax Reports First Quarter 2024 Financial Results and Operational Highlights PR Newswire GAITHERSBURG, Md., May 10, 2024 Announces co-exclusive licensing agreement with ...
Novavax stock explodes 75% on Sanofi partnership By Investing.com
Investing.com· 5 hours agoNovavax (NASDAQ:NVAX) shares rocketed 75% in premarket trading Friday, driven by the company’s...
Novavax, Sanofi Ink Deal to Commercialize COVID-19 Vaccine to Jointly Produce Combination Shots -...
EconoTimes· 4 hours agoNovavax, Inc., a biotechnology company headquartered in Gaithersburg, Maryland, revealed on Friday,...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 7 hours agoNovavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine and Develop Novel COVID-19-Influenza Combination Vaccines PR Newswire GAITHERSBURG ...
Novavax erases doubts about its ability to remain in business
Reuters via AOL· 7 hours agoIn February, Novavax had raised doubts about its ability to remain in business and announced plans...